KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Convertible Debt (2017 - 2026)

Teladoc Health's Convertible Debt history spans 10 years, with the latest figure at $995.8 million for Q1 2026.

  • On a quarterly basis, Convertible Debt fell 35.46% to $995.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $995.8 million, a 35.46% decrease, with the full-year FY2025 number at $994.9 million, down 35.48% from a year prior.
  • Convertible Debt hit $995.8 million in Q1 2026 for Teladoc Health, roughly flat from $994.9 million in the prior quarter.
  • Over the last five years, Convertible Debt for TDOC hit a ceiling of $1.5 billion in Q1 2025 and a floor of $989.7 million in Q2 2024.
  • Historically, Convertible Debt has averaged $1.3 billion across 5 years, with a median of $1.5 billion in 2022.
  • Biggest five-year swings in Convertible Debt: skyrocketed 401.24% in 2022 and later tumbled 35.61% in 2024.
  • Tracing TDOC's Convertible Debt over 5 years: stood at $1.5 billion in 2022, then grew by 0.22% to $1.5 billion in 2023, then rose by 0.22% to $1.5 billion in 2024, then plummeted by 35.48% to $994.9 million in 2025, then grew by 0.09% to $995.8 million in 2026.
  • Business Quant data shows Convertible Debt for TDOC at $995.8 million in Q1 2026, $994.9 million in Q4 2025, and $994.0 million in Q3 2025.